{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:50:06Z","timestamp":1790524206521,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Pioneering Study Grant"},{"name":"Hungarian Ministry of Health","award":["ETT 353\/2006"],"award-info":[{"award-number":["ETT 353\/2006"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Peptides"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.regpep.2011.01.007","type":"journal-article","created":{"date-parts":[[2011,2,9]],"date-time":"2011-02-09T09:33:05Z","timestamp":1297243985000},"page":"1-5","source":"Crossref","is-referenced-by-count":10,"title":["Plasma nociceptin\/orphanin FQ levels are lower in patients with chronic ischemic cardiovascular diseases\u2014A pilot study"],"prefix":"10.1016","volume":"169","author":[{"given":"Mikl\u00f3s","family":"Krepuska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"S\u00f3tonyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"Csobay-Nov\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Szeberin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Harty\u00e1nszky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endre","family":"Zima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00f3ra","family":"Szil\u00e1gyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferenc","family":"Horkay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9la","family":"Merkely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"Acs\u00e1dy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korn\u00e9lia","family":"Tekes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.regpep.2011.01.007_bb0005","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/jnr.21565","article-title":"Bacterial lipopolysaccharide regulates nociceptin expression in sensory neurons","volume":"86","author":"Acosta","year":"2008","journal-title":"J Neurosci Res"},{"issue":"Suppl 2","key":"10.1016\/j.regpep.2011.01.007_bb0010","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s003930050241","article-title":"Plasma levels on nociceptin in female fibromyalgia syndrome patients","volume":"57","author":"Anderberg","year":"1998","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.regpep.2011.01.007_bb0015","doi-asserted-by":"crossref","first-page":"H477","DOI":"10.1152\/ajpheart.2000.278.2.H477","article-title":"Relationship between nociceptin\/orphanin FQ and cerebral hemodynamics after hypoxia\u2013ischemia in piglets","volume":"278","author":"Armstead","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.regpep.2011.01.007_bb0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0304-3959(98)00130-4","article-title":"Identification of nociceptin in human cerebrospinal fluid: comparison of levels in pain and non-pain states","volume":"78","author":"Brooks","year":"1998","journal-title":"Pain"},{"key":"10.1016\/j.regpep.2011.01.007_bb0025","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/sj.bjp.0703219","article-title":"Pharmacology of nociceptin and its receptor: a novel therapeutic target","volume":"129","author":"Calo","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.regpep.2011.01.007_bb0030","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/circ.54.3.947585","article-title":"Letter: grading of angina pectoris","volume":"54","author":"Campeau","year":"1976","journal-title":"Circulation"},{"key":"10.1016\/j.regpep.2011.01.007_bb0035","doi-asserted-by":"crossref","first-page":"PL241","DOI":"10.1016\/S0024-3205(97)00087-8","article-title":"Nociceptin, an endogenous ligand for the ORL1 receptor, has novel hypotensive activity in the rat","volume":"60","author":"Champion","year":"1997","journal-title":"Life Sci"},{"key":"10.1016\/j.regpep.2011.01.007_bb0040","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0196-9781(97)00178-2","article-title":"Decreases in systemic arterial and hindquarters perfusion pressure in response to nociceptin are not inhibited by naloxone in the rat","volume":"18","author":"Czapla","year":"1997","journal-title":"Peptides"},{"key":"10.1016\/j.regpep.2011.01.007_bb0045","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0196-9781(97)00014-4","article-title":"Nociceptin, an endogenous ligand for the ORL1 receptor, has vasodilator activity in the hindquarters vascular bed of the rat","volume":"18","author":"Czapla","year":"1997","journal-title":"Peptides"},{"key":"10.1016\/j.regpep.2011.01.007_bb0050","first-page":"742","article-title":"Cardiovascular and renal effects of nociceptin\/orphanin FQ: a new mediator to target?","volume":"8","author":"Doggrell","year":"2007","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.regpep.2011.01.007_bb0055","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1468-2982.2004.00664.x","article-title":"Circulating nociceptin levels during the cluster headache period","volume":"24","author":"Ertsey","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1016\/j.regpep.2011.01.007_bb0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1468-2982.2004.00849.x","article-title":"Plasma nociceptin levels are reduced in migraine without aura","volume":"25","author":"Ertsey","year":"2005","journal-title":"Cephalalgia"},{"key":"10.1016\/j.regpep.2011.01.007_bb0065","doi-asserted-by":"crossref","first-page":"10498","DOI":"10.1021\/bi0300635","article-title":"Human neutrophils as a source of nociceptin: a novel link between pain and inflammation","volume":"42","author":"Fiset","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.regpep.2011.01.007_bb0070","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.peptides.2009.06.018","article-title":"Plasma nociceptin\/orphanin FQ levels rise after spontaneous episodes of angina, but not during induced myocardial ischemia","volume":"30","author":"Fontana","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.regpep.2011.01.007_bb0075","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1161\/CIRCULATIONAHA.107.187930","volume":"116","author":"Fraker","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.regpep.2011.01.007_bb0080","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0014-2999(97)01076-5","article-title":"Prejunctional modulation by nociceptin of nerve-mediated inotropic responses in guinea-pig left atrium","volume":"332","author":"Giuliani","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.regpep.2011.01.007_bb0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0014-2999(97)01128-X","article-title":"Effect of nociceptin on heart rate and blood pressure in anaesthetized rats","volume":"333","author":"Giuliani","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.regpep.2011.01.007_bb0090","doi-asserted-by":"crossref","first-page":"PL141","DOI":"10.1016\/S0024-3205(96)00696-0","article-title":"Nociceptin: an endogenous agonist for central opioid like1 (ORL1) receptors possesses systemic vasorelaxant properties","volume":"60","author":"Gumusel","year":"1997","journal-title":"Life Sci"},{"key":"10.1016\/j.regpep.2011.01.007_bb0095","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.neulet.2008.01.042","article-title":"Acute myocardial ischemia up-regulates nociceptin\/orphanin FQ in dorsal root ganglion and spinal cord of rats","volume":"433","author":"Guo","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.regpep.2011.01.007_bb0100","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0361-9230(02)00795-5","article-title":"Elevated plasma nociceptin level in patients with Wilson disease","volume":"58","author":"Hantos","year":"2002","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.regpep.2011.01.007_bb0105","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3748\/wjg.v10.i1.152","article-title":"Rising plasma nociceptin level during development of HCC: a case report","volume":"10","author":"Horvath","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.regpep.2011.01.007_bb0120","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1139\/y98-019","article-title":"Antinociceptive and morphine modulatory actions of spinal orphanin FQ","volume":"76","author":"Jhamandas","year":"1998","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.regpep.2011.01.007_bb0125","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1124\/jpet.104.082768","article-title":"Functional selectivity of nociceptin\/orphanin FQ peptide receptor partial agonists on cardiovascular and renal function","volume":"314","author":"Kapusta","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.regpep.2011.01.007_bb0130","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1440-1681.2002.03639.x","article-title":"Nociceptin\/orphanin FQ modulates the cardiovascular, but not renal, responses to stress in spontaneously hypertensive rats","volume":"29","author":"Kapusta","year":"2002","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.regpep.2011.01.007_bb0135","first-page":"PL15","article-title":"Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ)","volume":"60","author":"Kapusta","year":"1997","journal-title":"Life Sci"},{"key":"10.1016\/j.regpep.2011.01.007_bb0140","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/00001756-200209160-00012","article-title":"Quantitative analysis of nociceptin in blood of patients with acute and chronic pain","volume":"13","author":"Ko","year":"2002","journal-title":"NeuroReport"},{"key":"10.1016\/j.regpep.2011.01.007_bb0145","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nrd2572","article-title":"The nociceptin\/orphanin FQ receptor: a target with broad therapeutic potential","volume":"7","author":"Lambert","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.regpep.2011.01.007_bb0150","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1365-2826.2009.01912.x","article-title":"Endogenous nociceptin \/ orphanin FQ system involvement in hypothalamic\u2013pituitary\u2013adrenal axis responses: relevance to models of inflammation","volume":"21","author":"Leggett","year":"2009","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.regpep.2011.01.007_bb0155","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/sj.bjp.0703746","article-title":"Blockade of mu-opioid receptors reveals the hyperalgesic effect of orphanin FQ\/nociceptin in the rat hot plate test","volume":"131","author":"Lutfy","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.regpep.2011.01.007_bb0160","first-page":"301","article-title":"Function of nociceptin and opioid OP4 receptors in the regulation of the cardiovascular system","volume":"53","author":"Malinowska","year":"2002","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.regpep.2011.01.007_bb0165","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1124\/jpet.103.051599","article-title":"Mu-opioid-induced desensitization of opioid receptor-like 1 and mu-opioid receptors: differential intracellular signaling determines receptor sensitivity","volume":"306","author":"Mandyam","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.regpep.2011.01.007_bb0170","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/377532a0","article-title":"Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor","volume":"377","author":"Meunier","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.regpep.2011.01.007_bb0175","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0031-6997(24)01502-3","article-title":"The molecular and behavioral pharmacology of the orphanin FQ\/nociceptin peptide and receptor family","volume":"53","author":"Mogil","year":"2001","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.regpep.2011.01.007_bb0180","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1126\/science.270.5237.792","article-title":"Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor","volume":"270","author":"Reinscheid","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.regpep.2011.01.007_bb0185","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3748\/wjg.v10.i1.42","article-title":"Increased nociceptin\/orphanin FQ plasma levels in hepatocellular carcinoma","volume":"10","author":"Szalay","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.regpep.2011.01.007_bb0190","first-page":"53","article-title":"Endogenous nociceptin level in ischemic stroke: connection to serotonin system","volume":"8","author":"Tekes","year":"2006","journal-title":"Neuropsychopharmacol Hung"},{"key":"10.1016\/j.regpep.2011.01.007_bb0195","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000497583","article-title":"Diabetes and endogenous orphanin FQ\/nociceptin levels in rat CSF and plasma","author":"Tekes","year":"2005","journal-title":"Int J Diab Metabol"},{"key":"10.1016\/j.regpep.2011.01.007_bb0200","first-page":"230","article-title":"Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology","volume":"28","author":"Vahanian","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.regpep.2011.01.007_bb0205","doi-asserted-by":"crossref","first-page":"R280","DOI":"10.1152\/ajpregu.00096.2008","article-title":"Chronic high-NaCl intake prolongs the cardiorenal responses to central N\/OFQ and produces regional changes in the endogenous brain NOP receptor system","volume":"296","author":"Wainford","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.regpep.2011.01.007_bb0210","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jneuroim.2003.12.018","article-title":"Nociceptin\/orphanin FQ modulates human T cell function in vitro","volume":"149","author":"Waits","year":"2004","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.regpep.2011.01.007_bb0215","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1213\/01.ane.0000278865.11991.9d","article-title":"Human peripheral blood mononuclear cells express nociceptin\/orphanin FQ, but not mu, delta, or kappa opioid receptors","volume":"105","author":"Williams","year":"2007","journal-title":"Anesth Analg"},{"key":"10.1016\/j.regpep.2011.01.007_bb0220","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1213\/ane.0b013e3181617646","article-title":"Human peripheral blood mononuclear cells produce pre-pro-nociceptin\/orphanin FQ mRNA","volume":"106","author":"Williams","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1016\/j.regpep.2011.01.007_bb0225","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/bja\/aen093","article-title":"Nociceptin and urotensin-II concentrations in critically ill patients with sepsis","volume":"100","author":"Williams","year":"2008","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.regpep.2011.01.007_bb0230","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0378-1119(99)00350-9","article-title":"The promoter region of human prepro-nociceptin gene and its regulation by cyclic AMP and steroid hormones","volume":"238","author":"Xie","year":"1999","journal-title":"Gene"}],"container-title":["Regulatory Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011511000292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011511000292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T13:07:57Z","timestamp":1740920877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167011511000292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":44,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0167011511000292"],"URL":"https:\/\/doi.org\/10.1016\/j.regpep.2011.01.007","relation":{},"ISSN":["0167-0115"],"issn-type":[{"value":"0167-0115","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}